12月11日，归创通桥-B(02190)盘中上涨5.09%，截至11:17，报11.98元/股，成交205.05万元。
归创通桥医疗科技股份有限公司是中国神经和外周血管介入医疗器械市场的领导者，主要为中国及海外的医生和患者提供治疗及应对神经和外周血管疾病的先进医疗器械。公司的主要治疗领域包括急性缺血性脑卒中、颅内动脉瘤、颈动脉狭窄、外周动脉和静脉疾病以及透析相关疾病。
截至2024年中报，归创通桥-B营业总收入3.66亿元、净利润6886.5万元。
12月10日，公司以每股11.28-11.5港元回购5万股,回购金额56.95万港元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.